A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting - Dranitsaris, G; Beegle, N; Kalberer, T (J Oncol Pharm Pract, 2015)
et al.